NCT03485950 Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam Status COMPLETED Phase PHASE2
NCT03485209 Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03484520 A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia Status TERMINATED Phase PHASE1
NCT03482713 Study of Gefapixant (MK-7264) in Adult Japanese Participants With Unexplained or Refractory Chronic Cough (MK-7264-033) Status COMPLETED Phase PHASE2
NCT03480802 A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults Infected With Human Immunodeficiency Virus (HIV) (V114-018) Status COMPLETED Phase PHASE3
NCT03480763 A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Healthy Adults 50 Years of Age or Older (V114-016/PNEU-PATH) Status COMPLETED Phase PHASE3
NCT03477175 Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Participants in Eisai Sponsored Lenvatinib Trials Status COMPLETED Phase PHASE2
NCT03474497 UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03473925 Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034) Status COMPLETED Phase PHASE2
NCT03470688 Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents Status UNKNOWN Phase N/A
NCT03461250 Chronic Hepatitis C in Chronic Hemodialysis Recipients - An Observational Study Status UNKNOWN Phase N/A
NCT03460899 Impact of Hypoglycaemia in Patients With Diabetes Mellitus Type 2 on Platelet Activation Status COMPLETED Phase NA
NCT03457948 Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03449238 Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients Status RECRUITING Phase PHASE1/PHASE2
NCT03449147 A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030) Status COMPLETED Phase PHASE3
NCT03449134 A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-027) Status COMPLETED Phase PHASE3
NCT03448666 ECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral Metastases Status WITHDRAWN Phase PHASE2
NCT03444376 The Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Advanced Cervical Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT03443869 Letermovir Versus Valganciclovir to Prevent Human Cytomegalovirus Disease in Kidney Transplant Recipients (MK-8228-002) Status COMPLETED Phase PHASE3